Institut Bergonie — Bordeaux

Public research footprint of Institut Bergonie, compiled from the ClinicalTrials.gov public registry.

463

Registered studies

167

Active

Recruiting now

225

Completed

Stopped or withdrawn

Most-studied conditions

Chronic Lymphocytic Leukemia · Follicular Lymphoma · Solid Tumors · Small Lymphocytic Lymphoma

Recently updated registry entries

NCT01272037 — Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in… (Active Not Recruiting)
NCT06772623 — Study to Evaluate Adverse Events and Efficacy of Intravenous (IV) Telisotuzumab… (Recruiting)
NCT07739459 — Study of Zanubrutinib in Older Patients With Previously Untreated Chronic Lymphocytic… (Not Yet Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Institut Bergonie?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 02, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.